Welcome to our dedicated page for Kenvue SEC filings (Ticker: KVUE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Kenvue Inc. (NYSE: KVUE) SEC filings, giving investors a primary source for the company’s regulatory disclosures. As the world’s largest pure-play consumer health company by revenue, Kenvue uses its SEC reports to detail financial performance, risk factors, governance matters and significant corporate events related to its portfolio of brands such as Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, Tylenol® and Zyrtec®.
Among the most important documents for KVUE are current reports on Form 8-K. In 2025, Kenvue filed several 8-Ks to furnish quarterly earnings press releases and to describe leadership changes, preliminary financial results and the Board’s comprehensive review of strategic alternatives. A key 8-K filed on November 3, 2025 outlines an Agreement and Plan of Merger with Kimberly-Clark Corporation, under which a Kimberly-Clark subsidiary will merge with and into Kenvue and Kenvue will ultimately become part of a wholly owned Kimberly-Clark subsidiary. That filing explains the merger structure, the cash and stock consideration for each share of Kenvue common stock, conditions to closing, and termination and fee provisions.
Investors can also use Kenvue’s filings to understand how management presents non-GAAP financial measures. The company’s 8-K earnings materials define metrics such as Adjusted gross profit margin, Adjusted operating income and margin, Adjusted net income, Adjusted diluted earnings per share, Adjusted EBITDA margin, Adjusted effective tax rate, Free cash flow and Organic sales, and reconcile them to the most comparable U.S. GAAP measures. These disclosures clarify how Kenvue evaluates operating efficiency, profitability and cash generation over time.
On this page, Stock Titan surfaces Kenvue’s SEC submissions as they are made available on EDGAR and pairs them with AI-powered summaries to explain the key points in plain language. Users can quickly scan new 10-K and 10-Q reports when filed, review 8-Ks for material events such as the Kimberly-Clark merger agreement or leadership transitions, and examine any proxy materials related to shareholder votes. This combination of real-time filings access and AI explanations helps investors follow how regulatory disclosures may affect KVUE shareholders and the future of the Kenvue business within the consumer health sector.
Dasgupta Anindya reported acquisition or exercise transactions in this Form 4 filing.
Kenvue Inc. reported that Group President APAC Anindya Dasgupta received a grant of 98,994 Restricted Stock Units on 03/02/2026. These RSUs correspond 1-for-1 with Kenvue common stock and were awarded at no purchase price. The award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, contingent on his continued service through each vesting date.
Kenvue Inc. vice president and chief accounting officer Heather Howlett reported several equity-compensation transactions. On March 2, 2026, she received a grant of 22,233 Restricted Stock Units that correspond 1-for-1 with Kenvue common stock and vest in three equal installments on March 2 of 2027, 2028, and 2029, subject to continued service. On March 3, 2026, 1,534.48 Restricted Stock Units were converted into the same number of common shares, and 526 shares of common stock were withheld at
Kenvue Inc. reported that Group President EMEA & LA Lawson Carlton acquired a grant of 93,488 restricted stock units. These RSUs carry no purchase price and correspond on a one-for-one basis with Kenvue common stock. The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, conditioned on Carlton’s continued service through each vesting date. This filing reflects equity-based compensation rather than an open-market share purchase or sale.
Kenvue Inc. reported that Chief People Officer Luani Alvarado acquired 79,407 Restricted Stock Units as a grant. Each unit corresponds 1-for-1 with Kenvue common stock and was awarded at no cash cost. The award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, contingent on continued service through each vesting date. Following this grant, Alvarado directly holds 79,407 restricted stock units.
Kenvue Inc. reported that Group President North America Carlos De Jesus acquired 127,051 restricted stock units (RSUs) on March 2, 2026 as an equity award. Each RSU corresponds one-for-one with Kenvue common stock. The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, contingent on his continued service with the company.
Perry Kirk reported acquisition or exercise transactions in this Form 4 filing.
Kenvue Inc. reported that Chief Executive Officer Perry Kirk received a grant of 491,662 restricted stock units that correspond one-for-one with Kenvue common stock. The award was granted on 03/02/2026 and will vest in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, subject to his continued service with the company.
Kenvue Inc. reported that Chief Scientific Officer Caroline Tillett acquired 63,525 Restricted Stock Units as an equity award. The units were granted at no cash cost and correspond one-for-one with Kenvue common stock.
This award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, as long as Tillett continues to serve at the company through each vesting date. All 63,525 RSUs are currently reported as directly owned following the grant.
Stevens Meredith reported acquisition or exercise transactions in this Form 4 filing.
Kenvue Inc. Chief Operations Officer Meredith Stevens received a grant of 92,641 restricted stock units that correspond 1-for-1 with Kenvue common stock. The award was granted as of 03/02/2026 and will vest in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, subject to her continued service.
Kenvue Inc. reported that Chief Digital & Marketing Officer Jonathan Halvorson acquired 51,879 restricted stock units as a compensation award. The units were granted at no cash cost and correspond one-for-one with Kenvue common stock. The award vests in three equal installments on 03/02/2027, 03/02/2028, and 03/02/2029, conditioned on his continued service with the company.
Kenvue Inc. reported that Chief Corp. Affairs Officer Russell Dyer acquired a grant of 43,673 restricted stock units (RSUs), each corresponding 1-for-1 with Kenvue common stock. The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029, contingent on his continued service through each vesting date.